Show simple item record

dc.contributor.authorGatenbee, CD
dc.contributor.authorBaker, A-M
dc.contributor.authorSchenck, RO
dc.contributor.authorStrobl, M
dc.contributor.authorWest, J
dc.contributor.authorNeves, MP
dc.contributor.authorHasan, SY
dc.contributor.authorLakatos, E
dc.contributor.authorMartinez, P
dc.contributor.authorCross, WCH
dc.contributor.authorJansen, M
dc.contributor.authorRodriguez-Justo, M
dc.contributor.authorWhelan, CJ
dc.contributor.authorSottoriva, A
dc.contributor.authorLeedham, S
dc.contributor.authorRobertson-Tessi, M
dc.contributor.authorGraham, TA
dc.contributor.authorAnderson, ARA
dc.coverage.spatialEngland
dc.date.accessioned2022-06-24T10:39:45Z
dc.date.available2022-06-24T10:39:45Z
dc.date.issued2022-04-04
dc.identifierARTN 1798
dc.identifier10.1038/s41467-022-29027-8
dc.identifier.citationNature Communications, 2022, 13 (1), pp. 1798 -
dc.identifier.issn2041-1723
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5192
dc.identifier.eissn2041-1723
dc.identifier.eissn2041-1723
dc.identifier.doi10.1038/s41467-022-29027-8
dc.description.abstractThe evolutionary dynamics of tumor initiation remain undetermined, and the interplay between neoplastic cells and the immune system is hypothesized to be critical in transformation. Colorectal cancer (CRC) presents a unique opportunity to study the transition to malignancy as pre-cancers (adenomas) and early-stage cancers are frequently resected. Here, we examine tumor-immune eco-evolutionary dynamics from pre-cancer to carcinoma using a computational model, ecological analysis of digital pathology data, and neoantigen prediction in 62 patient samples. Modeling predicted recruitment of immunosuppressive cells would be the most common driver of transformation. As predicted, ecological analysis reveals that progressed adenomas co-localized with immunosuppressive cells and cytokines, while benign adenomas co-localized with a mixed immune response. Carcinomas converge to a common immune "cold" ecology, relaxing selection against immunogenicity and high neoantigen burdens, with little evidence for PD-L1 overexpression driving tumor initiation. These findings suggest re-engineering the immunosuppressive niche may prove an effective immunotherapy in CRC.
dc.formatElectronic
dc.format.extent1798 -
dc.languageeng
dc.language.isoeng
dc.publisherNATURE PORTFOLIO
dc.relation.ispartofNature Communications
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAdenoma
dc.subjectBiological Evolution
dc.subjectCarcinoma
dc.subjectColorectal Neoplasms
dc.subjectHumans
dc.subjectImmunotherapy
dc.titleImmunosuppressive niche engineering at the onset of human colorectal cancer.
dc.typeJournal Article
dcterms.dateAccepted2022-02-24
dc.date.updated2022-06-24T10:38:46Z
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1038/s41467-022-29027-8
rioxxterms.licenseref.startdate2022-04-04
rioxxterms.typeJournal Article/Review
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/35379804
pubs.issue1
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Evolutionary Genomics & Modelling
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Genomics and evolutionary dynamics
pubs.publication-statusPublished online
pubs.volume13
icr.researchteamEvol Genomics & Modelling
icr.researchteamGenomics & evolut dynam
dc.contributor.icrauthorBaker, Ann-Marie Clare
dc.contributor.icrauthorSottoriva, Andrea
dc.contributor.icrauthorGraham, Trevor


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/